Mycobacterium tuberculosis, whole genome sequencing, WHO catalogue, resistance-conferring mutation, genome-based resistance prediction, antibiotic resistance
SARS-CoV-2 vaccines, breakthrough SARS-CoV-2 infection, correlates of protection, hematological malignancies, allogeneic stem cell transplantation, autologous stem cell transplantation, COVID-19, vaccine, immunocompromised patients, Moderna mRNA-1273, Pfiz
Klebsiella pneumoniae, third-generation cephalosporin resistant, carbapenem resistance, transmission, lineage ST307
MALDI-TOF Ms, Pseudomonas aeruginosa, antimicrobial susceptibility, blood culture, Carbapenem, meropenem.
BIOFIRE® Blood Culture Identification 2 (BCID2) Panel, Multidrug-resistant bacteria (MDRB), MDRB colonization, surveillance cultures, sepsis/septic shock
COVID-19, Vaccines, Side effects, survey, Spain
antimicrobial susceptibility, aztreonam/avibactam, cefiderocol, MALDI-TOF MS, turbidimetry, Synergy testing, MBL-producing Enterobacterales
Aspergillus, pulmonary aspergillosis, mannoprotein, Galactomannan, lateral flow immunoassay, Platelia® Galactomannan immunoassay, Virclia® Galactomannan monotest
Mycobacterium tuberculosis, Abbott RealTime Mycobacterium tuberculosis (MTB) PCR. Mycobacterial culture, non-tuberculous mycobacterial (NTM) lung disease.
SARS-CoV-2, COVID-19 vaccine, T-cell immunity, anti-RBD antibodies, booster